Influence of serum collected from rat perfused with compound Biejiaruangan drug on hepatic stellate cells.

AIM To observe the effect of compound Biejiaruangan decoction (CBJRGC) (composite prescription of Carapax trionycis for softening the liver) on proliferation, activation, excretion of collagen and cytokine of hepatic stellate cells (HSCs) and to find the mechanism of prevention and treatment of hepatic fibrosis by CBJRGC. METHODS Using MTT, immunohistochemistry and image analysis technology, the related indexes for proliferation, activation, excretion of collagen and cytokine of hepatic stellate cells were detected in 24 h, 48 h, and 72 h after administration of different dosages of CBJRGC. RESULTS Statistical analysis showed that serum collected from rat perfused with CBJRGC could restrain the proliferation of HSC in 48 h and 72 h especially in high and medium dosage groups, markedly decrease the expression of desmin, synapsin and platelet derived growth factor (PDGF) in HSC in 24 h, 48 h and 72 h, as well as the expression of alpha-SMA, collagen III, TIMP and TGFbeta1 in 48 h and 72 h, decrease the excretion of collagen I in 72 h. CBJRGC serum had no significant effect on collagens I, III and TIMP in 24 h. CONCLUSION CBJRGC serum has a good curative effect on hepatic fibrosis. Its main mechanism may be related to the following factors. The drug serum can restrain the proliferation and activation of HSC, decrease the number of activated HSC and the total number of HSC, the excretion of collagens I, III, enhance the degradation of collagen and restore the balance of synthesis and degradation of collagen, inhibit the expression of transforming growth factor beta1 (TGFalpha1) and platelet derived growth factor (PDGF) in HSC, block and delay the process of hepatic fibrosis. Synapsin is a new marker of activation of HSC, which provides a theoretical and testing basis for neural regulation in the developing process of hepatic fibrosis.

[1]  K. Kharbanda,et al.  Inhibition of markers of hepatic stellate cell activation by the hormone relaxin. , 2003, Biochemical pharmacology.

[2]  S. Brenner,et al.  Duplication, degeneration and subfunctionalization of the nested synapsin-Timp genes in Fugu. , 2003, Trends in genetics : TIG.

[3]  Wen-bin Liu,et al.  Inhibition on the production of collagen type I, III of activated hepatic stellate cells by antisense TIMP-1 recombinant plasmid. , 2003, World journal of gastroenterology.

[4]  R. Hultcrantz,et al.  The Myofibroblastic Conversion of Peribiliary Fibrogenic Cells Distinct from Hepatic Stellate Cells Is Stimulated by Platelet-Derived Growth Factor During Liver Fibrogenesis , 2003, Laboratory Investigation.

[5]  R. Kalluri,et al.  Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. , 2003, Gastroenterology.

[6]  H. Yoshiji,et al.  Tissue inhibitor of metalloproteinases‐1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse , 2002, Hepatology.

[7]  Nong Zhang,et al.  Effect of retinoid kappa receptor alpha (RXRalpha) transfection on the proliferation and phenotype of rat hepatic stellate cells in vitro. , 2002, Chinese medical journal.

[8]  A. Gressner,et al.  Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[9]  G. Marinos,et al.  Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. , 2002, Liver.

[10]  J. Nan,et al.  Aloe emodin suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. , 2002, Pharmacology & toxicology.

[11]  John P. Iredale,et al.  Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition , 2002, The Journal of Biological Chemistry.

[12]  Ping Wang,et al.  [Expression and significance of platelet derived growth factor and its receptor in liver tissues of patients with liver fibrosis]. , 2002, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[13]  D. Bissell Chronic liver injury, TGF-β, and cancer , 2001, Experimental & Molecular Medicine.

[14]  R. Hernández-Muñoz,et al.  Adenosine reverses a preestablished CCl4‐induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats , 2001, Hepatology.

[15]  J. Iredale Hepatic Stellate Cell Behavior during Resolution of Liver Injury , 2001, Seminars in liver disease.

[16]  S. Kojima,et al.  Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta. , 2001, Gastroenterology.

[17]  K. Okita,et al.  Characteristics of the cell proliferation profile of activated rat hepatic stellate cells in vitro in contrast to their fibrogenesis activity , 2001, Journal of Gastroenterology.

[18]  M. Manns,et al.  Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C. , 2001, Journal of hepatology.

[19]  P. Greengard,et al.  Identification of synapsin I peptides that insert into lipid membranes. , 2001, The Biochemical journal.

[20]  Manoel Luis Costa,et al.  Intermediate filaments modulation in an in vitro model of the hepatic stellate cell activation or conversion into the lipocyte phenotype. , 2001, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[21]  D. Bissell Chronic liver injury, TGF-beta, and cancer. , 2001, Experimental & molecular medicine.

[22]  S. Thorgeirsson,et al.  Tissue inhibitor of metalloproteinases‐1 promotes liver fibrosis development in a transgenic mouse model , 2000, Hepatology.

[23]  N. Shiojiri,et al.  Immunohistochemical analysis of development of desmin‐positive hepatic stellate cells in mouse liver , 2000, Journal of anatomy.

[24]  X. Liu,et al.  [Inhibition of the activation and collagen production of cultured rat hepatic stellate cells by antisense oligonucleotides against transforming growth factor-beta 1 is enhanced by cationic liposome delivery]. , 2000, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao.

[25]  J. Zhang,et al.  Expression of fibronectin receptor, integrin alpha 5 beta 1 of hepatic stellate cells in rat liver fibrosis. , 2000, Chinese medical journal.

[26]  R. Gebhardt,et al.  Common myofibroblastic features of newborn rat astrocytes and cirrhotic rat liver stellate cells in early cultures and in vivo , 1999, Neurochemistry International.

[27]  Q. Zhang,et al.  [Effects of interferon-alpha on the mRNA expression of procollagen type I and III of hepatic stellate cells and on the deposition of collagen type I and III in fibrotic liver of rats]. , 1999, Zhonghua yi xue za zhi.

[28]  A. Burt Pathobiology of hepatic stellate cells , 1999, Journal of Gastroenterology.

[29]  H. Tsukamoto,et al.  Cytokine regulation of hepatic stellate cells in liver fibrosis. , 1999, Alcoholism, clinical and experimental research.

[30]  A. Desmoulière,et al.  Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells. , 1999, Journal of hepatology.

[31]  C. Liu,et al.  Effects of Fuzhenghuayu decoction on collagen synthesis of cultured hepatic stellate cells, hepatocytes and fibroblasts in rats. , 1998, World journal of gastroenterology.

[32]  P. Calès Apoptosis and liver fibrosis: antifibrotic strategies. , 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.